Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Xeris Biopharma Holdings, Inc. shareholders
As of Jun 30, 2026, 230 institutions reported holding Xeris Biopharma Holdings, Inc., 59.4% of its shares. Largest: BlackRock, Vanguard and D. E. Shaw & Co., Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Xeris Biopharma Holdings, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 14.5M | 8.0% | +1.58M | Aug 7, 2026 |
| Vanguard | 11.4M | 6.3% | +436K | Aug 13, 2026 |
| D. E. Shaw & Co., Inc. | 7.8M | 4.3% | +15,947 | Aug 14, 2026 |
| State Street | 4.82M | 2.6% | +163K | Aug 7, 2026 |
| Geode Capital | 4.72M | 2.6% | +428K | Aug 12, 2026 |
| Nuveen | 4.39M | 2.4% | +1.47M | Aug 11, 2026 |
| Rosalind Advisors, Inc. | 2.91M | 1.6% | −323K | Aug 14, 2026 |
| Qube Research & Technologies Ltd | 2.89M | 1.6% | −1.22M | Aug 14, 2026 |
| Wellington | 2.37M | 1.3% | +194K | Aug 14, 2026 |
| Morgan Stanley | 2.34M | 1.3% | −236K | Aug 13, 2026 |